Abstract:Thioredoxin domain-containing 5 (TXNDC5) is reportedly overexpressed in colorectal cancer (CRC) and is therefore considered an oncogene. However, the role of TXNDC5 in CRC tumorigenesis remains unclear. The present study aimed to explore the role of TXNDC5 in CRC tumorigenesis in vitro and in vivo under hypoxic and normoxic conditions. Analyses of patient tissue samples revealed a positive association between the expression of hypoxia-inducible factor-1 (HIF-1 alpha) or TXNDC5 and the TNM stage of CRC. In addition, a positive correlation between the expression levels of HIF-1 alpha and TXNDC5 was observed in CRC tissues. Furthermore, culturing RKO and HCT-116 human CRC cell lines under hypoxic conditions significantly increased the expression levels of HIF-1 alpha and TXNDC5, whereas knockdown of HIF-1 alpha abolished the hypoxia-induced expression of TXNDC5. Knockdown of TXNDC5 significantly decreased cell proliferation and colony formation, and increased apoptosis of both cell lines. Furthermore, knockdown of TXNDC5 markedly increased hypoxia-induced reactive oxygen species (ROS) generation, and the expression of hypoxia-induced endoplasmic reticulum stress (ER) markers (CCAAT-enhancer-binding protein homologous protein, glucose-regulated protein 78 and activating transcription factor 4) and apoptotic markers (B-cell lymphoma 2-associated X protein and cleaved caspase-8). In addition, the expression levels of TXNDC5 were significantly increased in tumor tissues compared with in adenoma and normal tissues in a mouse model of CRC tumorigenesis. In conclusion, the in vivo data demonstrated that TXNDC5 is overexpressed in CRC tissues, and this overexpression may be associated with unfavorable clinicopathological features. The in vitro data indicated that hypoxia may induce TXNDC5 expression via upregulating HIF-1 alpha; this effect promoted CRC cell proliferation and survival under hypoxic conditions, likely via inhibiting hypoxia-induced ROS/ER stress signaling. These findings suggested that TXNDC5 functions as an important stress survival factor to maintain tumorigenesis of CRC cells under hypoxia by regulating hypoxia-induced ROS/ER stress signaling. The present study provided novel insights into the role of TXNDC5 in the tumorigenesis of CRC.

Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?

TXNDC5 Plays a Crucial Role in Regulating Endoplasmic Reticulum Activity through Different ER Stress Signaling Pathways in Hepatic Cells

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

[Progress of Research on TXNDC5].

Role of TXNDC5 in Tumorigenesis of Colorectal Cancer Cells: in Vivo and in Vitro Evidence

TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target

The Role of TXNIP in Cancer: a Fine Balance Between Redox, Metabolic, and Immunological Tumor Control

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

Thioredoxin Signaling Pathways in Cancer

Endoplasmic Reticulum Protein TXNDC5 Interacts with PRDX6 and HSPA9 to Regulate Glutathione Metabolism and Lipid Peroxidation in the Hepatic AML12 Cell Line

Redox-Dependent And Independent Effects Of Thioredoxin Interacting Protein

TXNIP Gene in Tumorigenesis and Metastasis

The role of TXNL1 in disease: treatment strategies for cancer and diseases with oxidative stress

The Role of TXNDC5 in Castration-Resistant Prostate Cancer-Involvement of Androgen Receptor Signaling Pathway.

TMX5/TXNDC15, a natural trapping mutant of the PDI family is a client of the proteostatic factor ERp44

Targeting the Thioredoxin System for Cancer Therapy.

Identification of Thioredoxin-1 As a Biomarker of Lung Cancer and Evaluation of Its Prognostic Value Based on Bioinformatics Analysis

Integrating Single-Cell and Bulk RNA Sequencing to Identify TXNRD1 As Effective Target for Prognostic and Therapeutic Strategy in Hepatocellular Carcinoma

The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target

Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical Review

Nitrosative/Oxidative Stress Conditions Regulate Thioredoxin-Interacting Protein (TXNIP) Expression and Thioredoxin-1 (TRX-1) Nuclear Localization